$CTSH

Morgan Stanley Just Upped Its Price Target on Cognizant Stock. Here's Why.

Morgan Stanley analyst James Faucette raised his price target on Cognizant (CTSH) to $51, citing the company’s differentiated AI strategy. The note follows Cognizant’s fiscal Q2 results: EPS of $1.37, slightly below the $1.38 estimate. Cognizant reported seven contracts over $100M each, operating margin at 16%, and raised full-year adjusted EPS to $5.70-$5.82, plus a $2B buyback.

Original reporting
Published Aug 1, 2026, 2:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 1, 2026, 2:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley Just Upped Its Price Target on Cognizant Stock. Here's Why. — source image
Decision brief

The 30-second read

$CTSHNeutralMed
01

Why it matters

The immediate tradable input is the Morgan Stanley price target increase, reinforced by references to AI positioning, seven large contracts, margin expansion, raised full-year adjusted EPS outlook, and a new $2B buyback plan.

02

Market read

A fresh sell-side price-target raise can move near-term positioning in CTSH, but the article’s framing suggests upside may be constrained by the stock’s continued weakness versus the prior close.

03

What to watch

The article highlights the stock is still down and the PT implies downside from the prior close, suggesting traders may focus on execution risk, contract conversion, and whether AI-driven inference cost declines translate into sustained applied-layer revenue.

Relevance 6/10Novelty 5/10Timing: pre-market today (published 2026-08-01)

Background

Cognizant (CTSH) has underperformed in 2026, and the article ties the latest sell-side note to AI strategy, recent Q2 results, and capital return.

Company-level read

Ticker impact

$CTSHNeutralMedium confidence
Context

Morgan Stanley raised its price target on Cognizant, citing the company’s differentiated AI strategy and positioning as inference costs decline.

Expected impact

Modest upside bias for CTSH on analyst-follow-through, but limited conviction given the article notes the stock is still down and the target implies potential downside.

Evidence & confidence

The text provides a specific new catalyst (price target increase) and links it to AI strategy, contracts, margin expansion, and a $2B buyback, but it also emphasizes the stock remains in the red and the target still suggests downside versus the prior close.

Market effects

Supports the broader IT services narrative that AI-driven differentiation and margin expansion can re-rate earnings quality.

No specific regional spillover beyond US-listed IT services sentiment.

Limited; the catalyst is company-specific (analyst PT and buyback) rather than a global macro or regulatory shift.

Counterpoint

The upgrade may be more about narrative (AI positioning) than a new fundamental datapoint, since the article’s key fundamentals (Q2 results, margin, outlook, contracts) are already tied to the just-reported quarter.

Key entities

  • Cognizant

    IT services firm whose stock is the subject of the analyst price-target increase and whose recent quarter included margin expansion, contract wins, and raised EPS outlook.

  • Morgan Stanley

    Raised its price target on CTSH, citing differentiated AI strategy and a value shift toward the applied layer.

Related articles

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMedAI 8/10

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.